| 2018 |
| 01/22 | （IR情報）15:00 平成29年12月期通期業績予想の修正に関するお知らせ |
| 01/16 | 3,115 | 3,115 | 3,085 | 3,090 | -0.8% | 12,200 | 889億9200万 | +2.18% |
| 01/15 | 3,075 | 3,115 | 3,075 | 3,115 | +1.96% | 31,900 | 897億1200万 | +3.21% |
| 01/12 | （IR情報）15:00 JAK阻害剤（皮膚外用製剤）JTE-052の国内第3相臨床試験（比較試験）の速報結果について |
| 01/12 | 3,050 | 3,070 | 3,040 | 3,055 | -0.33% | 20,200 | 879億8400万 | +1.33% |
| 01/11 | 3,065 | 3,065 | 3,040 | 3,065 | -0.33% | 18,300 | 882億7200万 | +1.73% |
| 01/10 | 3,055 | 3,080 | 3,030 | 3,075 | +0.33% | 20,700 | 885億6000万 | +2.16% |
| 01/09 | 3,100 | 3,105 | 3,055 | 3,065 | -1.45% | 23,800 | 882億7200万 | +1.96% |
| 01/05 | 3,050 | 3,120 | 3,045 | 3,110 | +1.97% | 40,100 | 895億6800万 | +3.56% |
| 01/04 | 3,020 | 3,060 | 3,020 | 3,050 | +0.83% | 28,500 | 878億4000万 | +1.67% |
| 2017 |
| 12/29 | 2,977 | 3,025 | 2,965 | 3,025 | +1.78% | 23,500 | 871億2000万 | +0.93% |
| 12/28 | 2,949 | 2,983 | 2,944 | 2,972 | +0.95% | 26,200 | 855億9360万 | -0.83% |
| 12/27 | 2,926 | 2,945 | 2,911 | 2,944 | -0.41% | 32,600 | 847億8720万 | -1.83% |
| 12/26 | 2,940 | 2,960 | 2,940 | 2,956 | +0.61% | 52,900 | 851億3280万 | -1.6% |
| 12/25 | 2,919 | 2,941 | 2,912 | 2,938 | +0.65% | 20,200 | 846億1440万 | -2.33% |
| 12/22 | 2,931 | 2,931 | 2,901 | 2,919 | -0.41% | 25,300 | 840億6720万 | -3.06% |
| 12/21 | 2,944 | 2,954 | 2,924 | 2,931 | -0.54% | 21,800 | 844億1280万 | -2.85% |
| 12/20 | 2,940 | 2,954 | 2,916 | 2,947 | -0.03% | 36,400 | 848億7360万 | -2.51% |
| 12/19 | 2,988 | 2,988 | 2,948 | 2,948 | -1.54% | 30,900 | 849億240万 | -2.67% |
| 12/18 | 3,030 | 3,030 | 2,987 | 2,994 | -1.19% | 40,700 | 862億2720万 | -1.35% |
| 12/15 | （IR情報）15:00 組織変更及び人事異動のお知らせ |
| 12/15 | 3,050 | 3,065 | 3,015 | 3,030 | -0.82% | 23,700 | 872億6400万 | -0.33% |
| 12/14 | 3,095 | 3,100 | 3,035 | 3,055 | -0.81% | 27,000 | 879億8400万 | +0.39% |
| 12/13 | 3,110 | 3,110 | 3,065 | 3,080 | +1.32% | 42,400 | 887億400万 | +1.18% |
| 12/12 | 3,070 | 3,070 | 3,035 | 3,040 | -0.98% | 13,700 | 875億5200万 | -0.13% |
| 12/11 | 3,070 | 3,120 | 3,035 | 3,070 | +0.49% | 26,900 | 884億1600万 | +0.82% |
| 12/08 | 3,145 | 3,165 | 3,030 | 3,055 | -0.65% | 80,400 | 879億8400万 | +0.33% |
| 12/07 | 2,928 | 3,080 | 2,920 | 3,075 | +4.31% | 53,900 | 885億6000万 | +0.99% |
| 12/06 | 3,000 | 3,015 | 2,945 | 2,948 | -2.55% | 48,600 | 849億240万 | -3.19% |
| 12/05 | 3,005 | 3,035 | 3,000 | 3,025 | +0.5% | 32,500 | 871億2000万 | -0.75% |
| 12/04 | 2,972 | 3,050 | 2,970 | 3,010 | +0.43% | 78,100 | 866億8800万 | -1.34% |
| 12/01 | 2,971 | 3,040 | 2,969 | 2,997 | +1.15% | 41,900 | 863億1360万 | -1.96% |
| 11/30 | 2,985 | 2,987 | 2,951 | 2,963 | -1.23% | 40,600 | 853億3440万 | -3.26% |
| 11/29 | 3,020 | 3,020 | 2,991 | 3,000 | -0.66% | 42,600 | 864億 | -2.44% |
| 11/28 | 3,015 | 3,025 | 2,993 | 3,020 | +0.94% | 36,400 | 869億7600万 | -2.01% |
| 11/27 | （5%ルール）エフィッシモキャピタルマネージメントピーティーイ…（8.43%） |
| 11/27 | 3,000 | 3,010 | 2,988 | 2,992 | -0.6% | 12,100 | 861億6960万 | -3.14% |
| 11/24 | 3,025 | 3,025 | 2,995 | 3,010 | -0.5% | 15,100 | 866億8800万 | -2.78% |
| 11/22 | 3,075 | 3,075 | 3,015 | 3,025 | -1.63% | 16,000 | 871億2000万 | -2.48% |
| 11/21 | 3,070 | 3,090 | 3,045 | 3,075 | +0.65% | 15,900 | 885億6000万 | -1.09% |
| 11/20 | 3,030 | 3,070 | 3,005 | 3,055 | +1.16% | 17,500 | 879億8400万 | -1.93% |
| 11/17 | 3,070 | 3,085 | 3,010 | 3,020 | -1.63% | 39,300 | 869億7600万 | -3.24% |
| 11/16 | 3,065 | 3,105 | 3,065 | 3,070 | -0.16% | 15,100 | 884億1600万 | -1.85% |
| 11/15 | 3,075 | 3,100 | 3,065 | 3,075 | -0.81% | 32,600 | 885億6000万 | -1.79% |
| 11/14 | 3,095 | 3,135 | 3,085 | 3,100 | +0.49% | 21,500 | 892億8000万 | -1.08% |
| 11/13 | 3,095 | 3,100 | 3,040 | 3,085 | -0.96% | 36,800 | 888億4800万 | -1.69% |
| 11/10 | 3,070 | 3,120 | 3,070 | 3,115 | -0.32% | 20,200 | 897億1200万 | -0.89% |
| 11/09 | 3,105 | 3,130 | 3,085 | 3,125 | +1.46% | 44,200 | 900億 | -0.7% |
| 11/08 | 3,035 | 3,085 | 3,035 | 3,080 | +0.49% | 12,900 | 887億400万 | -2.19% |
| 11/07 | 3,070 | 3,070 | 3,035 | 3,065 | -0.16% | 33,800 | 882億7200万 | -2.79% |
| 11/06 | 3,060 | 3,075 | 3,035 | 3,070 | +0.33% | 17,900 | 884億1600万 | -2.79% |
| 11/02 | 3,055 | 3,065 | 3,035 | 3,060 | 0% | 20,700 | 881億2800万 | -3.32% |
| 11/01 | 3,070 | 3,075 | 3,040 | 3,060 | -0.33% | 21,400 | 881億2800万 | -3.29% |
| 10/31 | 3,080 | 3,080 | 3,040 | 3,070 | +0.99% | 30,900 | 884億1600万 | -2.94% |
| 10/30 | 3,095 | 3,115 | 3,025 | 3,040 | -1.78% | 60,100 | 875億5200万 | -3.83% |
| 10/27 | 3,020 | 3,115 | 3,020 | 3,095 | -2.06% | 74,200 | 891億3600万 | -2.03% |
| 10/26 | （IR情報）15:00 2017年12月期第3四半期決算参考資料 |
| 10/26 | （IR情報）15:00 平成29年12月期第3四半期決算短信〔日本基準〕(非連結) |
| 10/26 | 3,140 | 3,180 | 3,115 | 3,160 | +0.16% | 35,000 | 910億800万 | +0.19% |
| 10/25 | 3,220 | 3,225 | 3,150 | 3,155 | -2.92% | 40,300 | 908億6400万 | +0.22% |
| 10/24 | 3,200 | 3,250 | 3,190 | 3,250 | +1.88% | 43,000 | 936億 | +3.47% |
| 10/23 | 3,180 | 3,195 | 3,165 | 3,190 | +0.31% | 20,600 | 918億7200万 | +1.98% |
| 10/20 | 3,150 | 3,195 | 3,150 | 3,180 | +0.63% | 19,900 | 915億8400万 | +1.99% |
| 10/19 | 3,145 | 3,180 | 3,145 | 3,160 | -0.16% | 21,300 | 910億800万 | +1.71% |
| 10/18 | 3,225 | 3,225 | 3,150 | 3,165 | -1.56% | 42,000 | 911億5200万 | +2.2% |
| 10/17 | 3,205 | 3,225 | 3,170 | 3,215 | +0.16% | 35,200 | 925億9200万 | +4.18% |
| 10/16 | 3,190 | 3,240 | 3,190 | 3,210 | +0.16% | 29,700 | 924億4800万 | +4.53% |
| 10/13 | 3,165 | 3,215 | 3,165 | 3,205 | +0.47% | 31,900 | 923億400万 | +4.88% |
| 10/12 | 3,170 | 3,205 | 3,165 | 3,190 | +1.11% | 21,400 | 918億7200万 | +4.9% |
| 10/11 | 3,170 | 3,170 | 3,150 | 3,155 | -0.16% | 18,100 | 908億6400万 | +4.26% |
| 10/10 | 3,180 | 3,180 | 3,150 | 3,160 | -0.63% | 19,300 | 910億800万 | +4.84% |
| 10/06 | 3,215 | 3,230 | 3,165 | 3,180 | -1.24% | 76,000 | 915億8400万 | +5.79% |
| 10/05 | （IR情報）15:00 スギ花粉症に対するアレルゲン免疫療法薬「シダキュアスギ花粉舌下錠」の発売予定時期に関するお知らせ |
| 10/05 | 3,195 | 3,225 | 3,190 | 3,220 | +0.16% | 25,400 | 927億3600万 | +7.44% |
| 10/04 | 3,170 | 3,235 | 3,155 | 3,215 | +0.94% | 37,200 | 925億9200万 | +7.63% |
| 10/03 | 3,180 | 3,200 | 3,130 | 3,185 | +0.47% | 39,300 | 917億2800万 | +7.09% |
| 10/02 | 3,170 | 3,190 | 3,160 | 3,170 | -0.94% | 35,100 | 912億9600万 | +6.99% |
| 09/29 | 3,240 | 3,255 | 3,170 | 3,200 | -1.23% | 63,400 | 921億6000万 | +8.36% |
| 09/28 | 3,455 | 3,455 | 3,230 | 3,240 | +6.75% | 206,400 | 933億1200万 | +10.09% |
| 09/27 | （IR情報）16:00 スギ花粉症に対するアレルゲン免疫療法薬「シダキュアスギ花粉舌下錠」の国内製造販売承認取得について |
| 09/27 | 3,010 | 3,035 | 2,999 | 3,035 | +0.5% | 17,000 | 874億800万 | +3.51% |
| 09/26 | 2,995 | 3,025 | 2,995 | 3,020 | 0% | 19,500 | 869億7600万 | +3.18% |
| 09/25 | 3,025 | 3,045 | 2,973 | 3,020 | +0.5% | 47,200 | 869億7600万 | +3.21% |
| 09/22 | 3,000 | 3,015 | 2,973 | 3,005 | +0.97% | 25,200 | 865億4400万 | +2.74% |
| 09/21 | 3,000 | 3,020 | 2,972 | 2,976 | -1.13% | 19,600 | 857億880万 | +1.74% |
| 09/20 | 2,970 | 3,035 | 2,958 | 3,010 | +1.69% | 39,500 | 866億8800万 | +2.87% |
| 09/19 | 2,974 | 2,974 | 2,918 | 2,960 | +0.68% | 25,400 | 852億4800万 | +1.23% |
| 09/15 | 2,946 | 2,956 | 2,922 | 2,940 | +0.58% | 43,800 | 846億7200万 | +0.51% |
| 09/14 | 2,936 | 2,945 | 2,912 | 2,923 | +0.38% | 27,400 | 841億8240万 | -0.14% |
| 09/13 | 2,912 | 2,936 | 2,903 | 2,912 | -0.41% | 13,300 | 838億6560万 | -0.61% |
| 09/12 | 2,900 | 2,925 | 2,893 | 2,924 | +1.49% | 23,600 | 842億1120万 | -0.37% |
| 09/11 | 2,888 | 2,906 | 2,869 | 2,881 | +1.44% | 19,100 | 829億7280万 | -2.11% |
| 09/08 | 2,826 | 2,860 | 2,826 | 2,840 | 0% | 25,100 | 817億9200万 | -3.7% |
| 09/07 | 2,857 | 2,876 | 2,826 | 2,840 | +0.14% | 26,900 | 817億9200万 | -3.92% |
| 09/06 | 2,789 | 2,846 | 2,750 | 2,836 | +1.54% | 30,600 | 816億7680万 | -4.29% |
| 09/05 | 2,875 | 2,878 | 2,791 | 2,793 | -2.82% | 31,100 | 804億3840万 | -6.02% |
| 09/04 | 2,958 | 2,958 | 2,874 | 2,874 | -2.84% | 22,700 | 827億7120万 | -3.69% |
| 09/01 | 2,956 | 2,964 | 2,928 | 2,958 | +0.03% | 19,100 | 851億9040万 | -1.04% |
| 08/31 | 2,961 | 2,981 | 2,937 | 2,957 | +0.1% | 20,900 | 851億6160万 | -0.74% |
| 08/30 | 2,934 | 2,969 | 2,925 | 2,954 | +1.58% | 24,100 | 850億7520万 | -0.51% |
| 08/29 | 2,900 | 2,912 | 2,878 | 2,908 | +0.28% | 18,900 | 837億5040万 | -1.69% |
| 08/28 | 2,912 | 2,930 | 2,873 | 2,900 | -0.72% | 21,200 | 835億2000万 | -1.66% |
| 08/25 | 2,936 | 2,936 | 2,901 | 2,921 | -0.65% | 22,800 | 841億2480万 | -0.68% |
| 08/24 | 2,975 | 2,988 | 2,930 | 2,940 | -0.98% | 19,600 | 846億7200万 | +0.24% |
| 08/23 | 2,950 | 3,005 | 2,924 | 2,969 | +1.5% | 48,600 | 855億720万 | +1.57% |
| 08/22 | 2,955 | 2,969 | 2,906 | 2,925 | -1.58% | 31,300 | 842億4000万 | +0.45% |
| 08/21 | 2,985 | 2,997 | 2,968 | 2,972 | -0.87% | 28,500 | 855億9360万 | +2.41% |
| 08/18 | 2,978 | 3,015 | 2,978 | 2,998 | -0.4% | 28,400 | 863億4240万 | +3.77% |
